Physician

David G. Telander, M.D., PH.D

According to 2025 Medicare claims, David Telander, M.D., PH.D (NPI: 1528043023) practices ophthalmology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Placer, CA. This provider's primary affiliated billing organization is VITREO-RETINAL MEDICAL GROUP, INC (NPI: 1669969960; TIN: 942442567) and primary practice location at 95661-3988. Telander is affiliated with the NeueHealth Premier ACO, LLC (ACO ID: D0181) and NeueHealth Community ACO, LLC (ACO ID: D0324), participating under the REACH model.

Telander's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,672 traditional Medicare patients, billed 69,193 HCPCS/CPT codes, and received $4,035,989 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 846 prescription claims across 286 beneficiaries totaling $46,630 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 109 records totaling $337,244. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,515	25,400	$4,167,063
2016	2,484	25,071	$4,292,555
2017	2,417	26,136	$4,459,562
2018	2,511	26,921	$4,622,447
2019	2,508	23,967	$4,018,371
2020	1,841	18,126	$3,261,224
2021	1,897	18,558	$3,513,771
2022	2,035	22,899	$3,989,409
2023	1,741	39,530	$3,635,538
2024	1,672	69,193	$4,035,989

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	288	779	$79,651
2016	326	939	$84,022
2017	314	924	$83,988
2018	318	835	$65,517
2019	337	930	$90,947
2020	295	907	$85,627
2021	317	988	$90,524
2022	310	910	$74,880
2023	282	816	$58,787
2024	286	846	$46,630

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	222	1,112	$658
92235	Exam of retinal blood vessels using a special camera after injection of a dye	318	340	$142
67028	Injection of drug into eye	499	1,748	$104
92014	Established patient complete exam of visual system	1,290	2,082	$99
92134	Imaging of retina	1,568	3,553	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	273	12,859	$13,933
Dorzolamide Hcl	Dorzolamide Hcl	137	8,010	$2,441
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	19	894	$2,004
Brinzolamide	Brinzolamide	16	1,131	$1,704
Ketorolac Tromethamine	Ketorolac Tromethamine	49	2,502	$1,669

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$4,241	Regeneron Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	84	$333,003	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David G. Telander, M.D., PH.D?

Tedicare shows public-source Medicare data for David G. Telander, M.D., PH.D (NPI 1528043023), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David G. Telander, M.D., PH.D have ACO affiliation data?

David G. Telander, M.D., PH.D is shown with ACO affiliation data for NeueHealth Premier ACO, LLC (REACH, ACO ID D0181) and NeueHealth Community ACO, LLC (REACH, ACO ID D0324).

What billing organization is linked to David G. Telander, M.D., PH.D?

David G. Telander, M.D., PH.D is linked to VITREO-RETINAL MEDICAL GROUP, INC (billing NPI 1669969960) in the available physician profile data.

Does David G. Telander, M.D., PH.D have Open Payments data?

David G. Telander, M.D., PH.D has 109 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.